.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Queensland Health
Covington
Argus Health
Daiichi Sankyo
QuintilesIMS
Dow
McKinsey
Fish and Richardson
AstraZeneca

Generated: December 12, 2017

DrugPatentWatch Database Preview

Ziprasidone hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ziprasidone hydrochloride and what is the scope of ziprasidone hydrochloride freedom to operate?

Ziprasidone hydrochloride
is the generic ingredient in two branded drugs marketed by Pfizer, Apotex Inc, Aurobindo Pharma Ltd, Dr Reddys Labs Inc, Lupin Pharms, Macleods Pharms Ltd, Mylan Pharms Inc, Sandoz Inc, Wockhardt Ltd, Zydus Pharms Usa Inc, and Pfizer Inc, and is included in eleven NDAs. There are three patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Ziprasidone hydrochloride has one hundred and thirty-two patent family members in fifty-three countries.

There are twenty-one drug master file entries for ziprasidone hydrochloride. Thirty-three suppliers are listed for this compound.

Pharmacology for ziprasidone hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
PfizerGEODONziprasidone hydrochlorideCAPSULE;ORAL020825-003Feb 5, 2001ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Lupin PharmsZIPRASIDONE HYDROCHLORIDEziprasidone hydrochlorideCAPSULE;ORAL077560-003Mar 2, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Pfizer IncGEODONziprasidone hydrochlorideSUSPENSION;ORAL021483-001Mar 29, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sandoz IncZIPRASIDONE HYDROCHLORIDEziprasidone hydrochlorideCAPSULE;ORAL077562-002Jun 1, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
PfizerGEODONziprasidone hydrochlorideCAPSULE;ORAL020825-001Feb 5, 2001ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa IncZIPRASIDONE HYDROCHLORIDEziprasidone hydrochlorideCAPSULE;ORAL208988-004Aug 22, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Macleods Pharms LtdZIPRASIDONE HYDROCHLORIDEziprasidone hydrochlorideCAPSULE;ORAL204375-004Feb 17, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Apotex IncZIPRASIDONE HYDROCHLORIDEziprasidone hydrochlorideCAPSULE;ORAL077561-001Mar 2, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Macleods Pharms LtdZIPRASIDONE HYDROCHLORIDEziprasidone hydrochlorideCAPSULE;ORAL204375-003Feb 17, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
PfizerGEODONziprasidone hydrochlorideCAPSULE;ORAL020825-002Feb 5, 2001ABRXYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: ziprasidone hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer IncGEODONziprasidone hydrochlorideSUSPENSION;ORAL021483-001Mar 29, 2006► Subscribe► Subscribe
PfizerGEODONziprasidone hydrochlorideCAPSULE;ORAL020825-001Feb 5, 2001► Subscribe► Subscribe
Pfizer IncGEODONziprasidone hydrochlorideSUSPENSION;ORAL021483-001Mar 29, 2006► Subscribe► Subscribe
PfizerGEODONziprasidone hydrochlorideCAPSULE;ORAL020825-004Feb 5, 2001► Subscribe► Subscribe
PfizerGEODONziprasidone hydrochlorideCAPSULE;ORAL020825-003Feb 5, 2001► Subscribe► Subscribe
PfizerGEODONziprasidone hydrochlorideCAPSULE;ORAL020825-002Feb 5, 2001► Subscribe► Subscribe
PfizerGEODONziprasidone hydrochlorideCAPSULE;ORAL020825-003Feb 5, 2001► Subscribe► Subscribe
PfizerGEODONziprasidone hydrochlorideCAPSULE;ORAL020825-002Feb 5, 2001► Subscribe► Subscribe
PfizerGEODONziprasidone hydrochlorideCAPSULE;ORAL020825-001Feb 5, 2001► Subscribe► Subscribe
PfizerGEODONziprasidone hydrochlorideCAPSULE;ORAL020825-004Feb 5, 2001► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: ziprasidone hydrochloride

Country Document Number Estimated Expiration
African Intellectual Property Organization (OAPI)11946► Subscribe
New Zealand336271► Subscribe
Brazil0010990► Subscribe
El Salvador2001000085► Subscribe
Norway320296► Subscribe
Bulgaria103489► Subscribe
Denmark1181018► Subscribe
Poland352826► Subscribe
Morocco26647► Subscribe
European Patent Office0931547► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Julphar
Accenture
Novartis
Medtronic
QuintilesIMS
Dow
Johnson and Johnson
Covington
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot